135 related articles for article (PubMed ID: 27393460)
21. The effect of common genetic variation in 11β-hydroxysteroid dehydrogenase type 1 on hypothalamic-pituitary-adrenal axis activity and incident depression.
Dekker MJ; Tiemeier H; Luijendijk HJ; Kuningas M; Hofman A; de Jong FH; Stewart PM; Koper JW; Lamberts SW
J Clin Endocrinol Metab; 2012 Feb; 97(2):E233-7. PubMed ID: 22112815
[TBL] [Abstract][Full Text] [Related]
22. Active site variability of type 1 11beta-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons.
Hult M; Shafqat N; Elleby B; Mitschke D; Svensson S; Forsgren M; Barf T; Vallgårda J; Abrahmsen L; Oppermann U
Mol Cell Endocrinol; 2006 Mar; 248(1-2):26-33. PubMed ID: 16431016
[TBL] [Abstract][Full Text] [Related]
23. The effects of high fat diet on the basal activity of the hypothalamus-pituitary-adrenal axis in mice.
Auvinen HE; Romijn JA; Biermasz NR; Pijl H; Havekes LM; Smit JW; Rensen PC; Pereira AM
J Endocrinol; 2012 Aug; 214(2):191-7. PubMed ID: 22619233
[TBL] [Abstract][Full Text] [Related]
24. 11beta-Hydroxysteroid Dehydrogenase Type 1 Regulation by Intracellular Glucose 6-Phosphate Provides Evidence for a Novel Link between Glucose Metabolism and Hypothalamo-Pituitary-Adrenal Axis Function.
Walker EA; Ahmed A; Lavery GG; Tomlinson JW; Kim SY; Cooper MS; Ride JP; Hughes BA; Shackleton CHL; McKiernan P; Elias E; Chou JY; Stewart PM
J Biol Chem; 2007 Sep; 282(37):27030-27036. PubMed ID: 17588937
[TBL] [Abstract][Full Text] [Related]
25. Reduced 11beta-hydroxysteroid dehydrogenase type 1 activity in obese boys.
Wiegand S; Richardt A; Remer T; Wudy SA; Tomlinson JW; Hughes B; Grüters A; Stewart PM; Strasburger CJ; Quinkler M
Eur J Endocrinol; 2007 Sep; 157(3):319-24. PubMed ID: 17766714
[TBL] [Abstract][Full Text] [Related]
26. Nicotine-induced over-exposure to maternal glucocorticoid and activated glucocorticoid metabolism causes hypothalamic-pituitary-adrenal axis-associated neuroendocrine metabolic alterations in fetal rats.
Xu D; Liang G; Yan YE; He WW; Liu YS; Chen LB; Magdalou J; Wang H
Toxicol Lett; 2012 Mar; 209(3):282-90. PubMed ID: 22265867
[TBL] [Abstract][Full Text] [Related]
27. 11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11β-HSD1 is knocked out in livers of male mice.
Harno E; Cottrell EC; Keevil BG; DeSchoolmeester J; Bohlooly-Y M; Andersén H; Turnbull AV; Leighton B; White A
Endocrinology; 2013 Oct; 154(10):3599-609. PubMed ID: 23832962
[TBL] [Abstract][Full Text] [Related]
28. Do alterations in placental 11beta-hydroxysteroid dehydrogenase (11betaHSD) activities explain differences in fetal hypothalamic-pituitary-adrenal (HPA) function following periconceptional undernutrition or twinning in sheep?
Connor KL; Challis JR; van Zijl P; Rumball CW; Alix S; Jaquiery AL; Oliver MH; Harding JE; Bloomfield FH
Reprod Sci; 2009 Dec; 16(12):1201-12. PubMed ID: 19767539
[TBL] [Abstract][Full Text] [Related]
29. The Dehydrogenase Hypothesis.
Woods C; Tomlinson JW
Adv Exp Med Biol; 2015; 872():353-80. PubMed ID: 26216003
[TBL] [Abstract][Full Text] [Related]
30. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity.
Rask E; Walker BR; Söderberg S; Livingstone DE; Eliasson M; Johnson O; Andrew R; Olsson T
J Clin Endocrinol Metab; 2002 Jul; 87(7):3330-6. PubMed ID: 12107245
[TBL] [Abstract][Full Text] [Related]
31. Structure-based design and synthesis of 1,3-oxazinan-2-one inhibitors of 11β-hydroxysteroid dehydrogenase type 1.
Xu Z; Tice CM; Zhao W; Cacatian S; Ye YJ; Singh SB; Lindblom P; McKeever BM; Krosky PM; Kruk BA; Berbaum J; Harrison RK; Johnson JA; Bukhtiyarov Y; Panemangalore R; Scott BB; Zhao Y; Bruno JG; Togias J; Guo J; Guo R; Carroll PJ; McGeehan GM; Zhuang L; He W; Claremon DA
J Med Chem; 2011 Sep; 54(17):6050-62. PubMed ID: 21786805
[TBL] [Abstract][Full Text] [Related]
32. Dysregulation of Hypothalamo-Pituitary-Adrenocortical Axis in Overweight Female Diabetic Subjects is Associated with Downregulation of Corticosteroid Receptors and 11β-HSD1 in the Brain.
Li S; Liao Y; Wang L; Huang R; Yue J; Xu H; Zhou H; Lou Z; Hu Y; Liu W
Horm Metab Res; 2016 Mar; 48(3):178-84. PubMed ID: 26212138
[TBL] [Abstract][Full Text] [Related]
33. Ethanol-induced inhibition of fetal hypothalamic-pituitary-adrenal axis due to prenatal overexposure to maternal glucocorticoid in mice.
Liang G; Chen M; Pan XL; Zheng J; Wang H
Exp Toxicol Pathol; 2011 Nov; 63(7-8):607-11. PubMed ID: 20627497
[TBL] [Abstract][Full Text] [Related]
34. Activation of the hypothalamic-pituitary-adrenal axis in obesity: cause or consequence?
Walker BR
Growth Horm IGF Res; 2001 Jun; 11 Suppl A():S91-5. PubMed ID: 11527096
[TBL] [Abstract][Full Text] [Related]
35. 11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?
Anagnostis P; Katsiki N; Adamidou F; Athyros VG; Karagiannis A; Kita M; Mikhailidis DP
Metabolism; 2013 Jan; 62(1):21-33. PubMed ID: 22652056
[TBL] [Abstract][Full Text] [Related]
36. Akebia saponin D reverses corticosterone hypersecretion in an Alzheimer's disease rat model.
Wang Y; Shen J; Yang X; Jin Y; Yang Z; Wang R; Zhang F; Linhardt RJ
Biomed Pharmacother; 2018 Nov; 107():219-225. PubMed ID: 30092401
[TBL] [Abstract][Full Text] [Related]
37. Is there sufficient evidence to consider the use of 11β-hydroxysteroid dehydrogenase type 1 inhibition in children?
Fürst-Recktenwald S; Dörr HG; Quinkler M; Dötsch J; Stewart PM
Clin Endocrinol (Oxf); 2012 Aug; 77(2):159-68. PubMed ID: 22486586
[TBL] [Abstract][Full Text] [Related]
38. The Hepato-Hypothalamic-Pituitary-Adrenal-Renal Axis: Mathematical Modeling of Cortisol's Production, Metabolism, and Seasonal Variation.
Pierre K; Schlesinger N; Androulakis IP
J Biol Rhythms; 2017 Oct; 32(5):469-484. PubMed ID: 28946788
[TBL] [Abstract][Full Text] [Related]
39. Structural characterization and pharmacodynamic effects of an orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitor.
Hale C; Véniant M; Wang Z; Chen M; McCormick J; Cupples R; Hickman D; Min X; Sudom A; Xu H; Matsumoto G; Fotsch C; St Jean DJ; Wang M
Chem Biol Drug Des; 2008 Jan; 71(1):36-44. PubMed ID: 18069989
[TBL] [Abstract][Full Text] [Related]
40. 11Beta-hydroxysteroid dehydrogenase type 1 in human disease: a novel therapeutic target.
Tomlinson JW
Minerva Endocrinol; 2005 Mar; 30(1):37-46. PubMed ID: 15877012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
